Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients

Figure 1 Survival analysis based on adherence to flupentixol-melitracen treatment among patients with functional dyspepsia. The survival analysis was calculated as the number of patients who remained therapy-compliant for each day of the study. Group 1 exhibited a significantly higher compliance rate than did those in Groups 2 and 3 (Group 1 vs Group 2, P = 0.002; Group 1 vs Group 3, P = 0.018).

Figure 2 Mean changes from baseline leeds dyspepsia questionnaire scores in functional dyspepsia patients based on the intent-to-treat population. ^aP < 0.05, ^bP < 0.01 vs Group 1. FD: Functional dyspepsia; LDQ: Leeds dyspepsia questionnaire.

Figure 3 Mean changes from baseline hospital anxiety and depression scale scores in functional dyspepsia patients based on the intent-to-treat population. A: Changes in the anxiety subscale; B: Changes in the depression subscale. ^aP < 0.05, ^bP < 0.01 vs Group 1. FD: Functional dyspepsia; HADS: Hospital anxiety and depression scale.